The follow‐up of progressive hypertrophic cardiomyopathy using magnetic resonance rotating frame relaxation times

Skip to Navigation

EarlyView Article

  • Published: Dec 15, 2017
  • Author: Muhammad Arsalan Khan, Hanne Laakso, Svetlana Laidinen, Sanna Kettunen, Tommi Heikura, Seppo Ylä‐Herttuala, Timo Liimatainen
  • Journal: NMR in Biomedicine

Magnetic resonance rotating frame relaxation times are an alternative non‐contrast agent choice for the diagnosis of chronic myocardial infarct. Fibrosis typically occurs in progressive hypertrophic cardiomyopathy. Fibrosis has been imaged in myocardial infarcted tissue using rotating frame relaxation times, which provides the possibility to follow up progressive cardiomyopathy without contrast agents. Mild and severe left ventricular hypertrophy were induced in mice by transverse aortic constriction, and the longitudinal rotating frame relaxation times (T) and relaxation along the fictitious field (TRAFF2, TRAFF3) were measured at 5, 10, 24, 62 and 89 days after transverse aortic constriction in vivo. Myocardial fibrosis was verified using Masson's trichrome staining. Increases in the relative relaxation time differences of T, together with TRAFF2 and TRAFF3, between fibrotic and remote tissues over time were observed. Furthermore, TRAFF2 and TRAFF3 showed higher relaxation times overall in fibrotic tissue than T. Relaxation time differences were highly correlated with an excess of histologically verified fibrosis. We found that TRAFF2 and TRAFF3 are more sensitive than T to hypertrophic cardiomyopathy‐related tissue changes and can serve as non‐invasive diagnostic magnetic resonance imaging markers to follow up the mouse model of progressive hypertrophic cardiomyopathy.

Social Links

Share This Links

Bookmark and Share

Microsites

Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in separation science? Visit our sister site separationsNOW.com

Copyright © 2018 John Wiley & Sons, Inc. All Rights Reserved